Elston George (CIK 1429932) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-24). Recent activity: Sell EYPT (5,000 shares), Buy EYPT (5,000 shares), Sell EYPT (64,953 shares), Buy EYPT (64,953 shares), Buy EYPT (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 5,000 | $0 |
| 2026-08-24 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 5,000 | $0 |
| 2026-08-24 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 64,953 | $0 |
| 2026-08-24 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 64,953 | $0 |
| 2026-05-27 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 7,500 | $0 |
| 2026-05-27 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 3,627 | $46,897 |
| 2026-03-06 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 5,000 | $0 |
| 2026-03-06 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 5,000 | $0 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 15,285 | $0 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 4,487 | $75,651 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 19,667 | $0 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 6,324 | $110,544 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 15,000 | $0 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 4,403 | $76,744 |
| 2025-12-23 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Sell | 5,000 | $0 |
| 2025-12-23 | EyePoint, Inc. (EYPT) | Chief Financial Officer | Buy | 5,000 | $0 |
| 2025-09-22 | EyePoint Pharmaceuticals, Inc. (EYPT) | Chief Financial Officer | Sell | 20,000 | $0 |
| 2025-09-22 | EyePoint Pharmaceuticals, Inc. (EYPT) | Chief Financial Officer | Buy | 20,000 | $0 |
| 2025-05-27 | EyePoint Pharmaceuticals, Inc. (EYPT) | Chief Financial Officer | Buy | 7,500 | $0 |
| 2025-05-27 | EyePoint Pharmaceuticals, Inc. (EYPT) | Chief Financial Officer | Sell | 2,202 | $12,507 |
来源：SEC Form 4 申报文件 · 截至 2026-08-24